All News

Battle over ESA coverage continues

Medi-Promotions to launch Medi-Scripts Plus prescription pad

FDA grants full approval of tipranavir.

U.S. payers to incorporate biogeneric agents into their formularies

2008 Medicare Part D premiums to rise 21%, according to study by Avalere Health.

CVS Caremark celebrates American Pharmacists Month

Mipomersen sodium is the new generic name for Isis Pharmaceuticals' anticholesterol drug ISIS 301012.

Aetna's New Jersey e-prescribing pilot shows increase in generics

FDA launches initiative to bolster generic drug program

FTC cites retail health clinics as having potential to expand.

Instead of giving out separate written information for six infant vaccines, the Centers for Disease Control & Prevention is proposing to combine them into one document.

CMS will begin rejecting Medicare claims that do not use NPI numbers.

Pharmacy and consumer groups approve of new FDA bill that will track drug safety after approval and speed some generic drugs to market.

Combination medication Azor receives FDA approval

Somatropin (Norditropin, Novo Nordisk) approved by FDA for Turner syndrome

President Bush signs law to delay implementation of tamper-resistant prescription pad rule six months

Recordkeeping requirements for chemical distributors may be revised by FDA

The Food and Drug Administration most emphatically is not against compounding of drugs, Steven Silverman, a key enforcement officer in that agency, told the National Association of Boards of Pharmacy recently.

The author relates his personal experience with mercury toxicity through dental amalgams and calls on pharmacists to watch out for the condition among their patients.

Advice on the area of collaborative drug therapy managment.

New branded Rxs, OTCs, home health care items, health & beauty, etc.

The International Pharmaceutical Federation addressed progress in identifying and dealing with issues related to ersatz (or replacement) drug products.

New Jersey woman sues hospital for drug error that led state to take away newborn daughter.

Pharmacists as licensed prescribers.

In its coverage of incidents of Tylenol tamperingin the 1980s, Drug Topics urged pharmacists not to panic.

The Centers for Medicare and Medicaid Services moves fowarded with implementing new tamper-restantant prescription pad rules.

An effort coordinated by the National Heart, Lung, and Blood Institute, the National Asthma Education and Prevention Program has created a comprehensive update to their asthma guidelines. The new guide emphasizes the importance of keeping the condition under control and highlights the fact that part of the process means appropriate use of both quick-relief and long-term control medications.

Not only are there effective antidiabetes treatments on the market, but drugs in development promise to expand patient options even further.